Laboratory diagnosis of anthrax
The Food and Drug Administration has reviewed Idaho Technology's 510(k) application and cleared the Joint Biological Agent Identification and Diagnostic System (JBAIDS) for use as an aid in the laboratory of diagnosis of anthrax. The JBAIDS Anthrax Detection System can detect the gene components of Bacillus anthracis in a variety of environmental sample types, and also clinical blood samples as well as cultured organisms.
The JBAIDS was selected by the US Department of Defense as the platform for use in rapid identification of over ten deadly pathogens associated with bioterrorism and diseases of military interest. The FDA clearance allows testing of blood and laboratory culture samples to aid in the laboratory identification of B anthracis, with results in less than one hour. The current method of growing, isolating and identifying a culture can take as long as several days for results.
Biomarkers for SIDS found in blood samples
US researchers have revealed the fingerprints of sudden infant death syndrome (SIDS) within blood...
Uncurling and 'gluing down' DNA molecules for sharper imaging
Researchers at Nagoya University have demonstrated techniques for stretching and immobilising DNA...
Novel 3D bioprinter can replicate human tissue
Biomedical engineers have invented a 3D printing system capable of fabricating structures that...
